Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Veeva Systems Inc. (VEEV) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Health Information Services
$197.37
+3.70 (1.91%)Did VEEV Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Veeva is one of their latest high-conviction picks.
Based on our analysis of 17 Wall Street analysts, VEEV has a bullish consensus with a median price target of $235.00 (ranging from $165.00 to $350.00). The overall analyst rating is Strong Buy (8.1/10). Currently trading at $197.37, the median forecast implies a 19.1% upside. This outlook is supported by 21 Buy, 7 Hold, and 1 Sell ratings.
Conversely, the most conservative target is provided by Gabriela Borges at Goldman Sachs, suggesting a 16.4% downside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for VEEV.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 4, 2026 | Citigroup | Tyler Radke | Neutral | Maintains | $190.00 |
| Jun 4, 2026 | Mizuho | Steven Valiquette | Outperform | Maintains | $270.00 |
| Jun 4, 2026 | Goldman Sachs | Gabriela Borges | Sell | Maintains | $165.00 |
| Jun 4, 2026 | Oppenheimer | Ken Wong | Outperform | Reiterates | $225.00 |
| Jun 4, 2026 | Canaccord Genuity | David Hynes | Hold | Maintains | $220.00 |
| Jun 4, 2026 | Stifel | David Grossman | Buy | Maintains | $230.00 |
| Jun 4, 2026 | Evercore ISI Group | Kirk Materne | In-Line | Maintains | $185.00 |
| Jun 4, 2026 | UBS | Karl Keirstead | Neutral | Maintains | $190.00 |
| Jun 4, 2026 | RBC Capital | Rishi Jaluria | Outperform | Reiterates | $275.00 |
| Jun 4, 2026 | BMO Capital | Sean Dodge | Market Perform | Maintains | $175.00 |
| Jun 4, 2026 | Wells Fargo | Stan Berenshteyn | Overweight | Maintains | $320.00 |
| Jun 4, 2026 | Barclays | Saket Kalia | Overweight | Maintains | $235.00 |
| Jun 4, 2026 | Baird | Joe Vruwink | Outperform | Maintains | $260.00 |
| Jun 4, 2026 | BTIG | David Larsen | Buy | Reiterates | $340.00 |
| Jun 4, 2026 | Needham | Ryan MacDonald | Buy | Reiterates | $270.00 |
| Jun 4, 2026 | Piper Sandler | Hannah Rudoff | Overweight | Maintains | $235.00 |
| May 18, 2026 | Oppenheimer | Outperform | Maintains | $N/A | |
| Apr 10, 2026 | Citigroup | Neutral | Downgrade | $N/A | |
| Mar 9, 2026 | Citigroup | Buy | Maintains | $N/A | |
| Mar 5, 2026 | Canaccord Genuity | Hold | Maintains | $N/A |
The following stocks are similar to Veeva based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Veeva Systems Inc. has a market capitalization of $31.37B with a P/E ratio of 33.6x. The company generates $3.32B in trailing twelve-month revenue with a 28.4% profit margin.
Revenue growth is +16.3% quarter-over-quarter, while maintaining an operating margin of +30.9% and return on equity of +13.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Cloud software solutions for life sciences industry.
The company generates revenue by offering industry-specific cloud-based applications that assist life sciences organizations in managing key operational functions such as customer relationships, clinical trials, and compliance. By providing a platform that enhances data integrity and collaboration, Veeva Systems targets a diverse customer base that includes both emerging biotech firms and established pharmaceutical companies.
Veeva Systems is instrumental in modernizing software systems in healthcare, ensuring regulatory compliance and improving operational efficiencies across the industry. Its comprehensive suite of products supports critical workflows in development, manufacturing, and commercialization, making it a pivotal player in the life sciences technology sector.
Healthcare
Health Information Services
7,928
Mr. Peter P. Gassner
United States
2013
The latest trading day saw Veeva Systems (VEEV) settling at $193.09, representing a -1.89% change from its previous close.
Veeva Systems (VEEV) concluded the recent trading session at $188.17, signifying a -2.15% move from its prior day's close.
Veeva Systems (VEEV) closed at $193.09, down 1.89% from the previous trading day.
Veeva Systems' decline of 1.89% signals potential market volatility, which may influence investor sentiment and future trading strategies for the stock.
Veeva Systems (VEEV) reported strong Q1 results, driven by increased Vault CRM migrations and AI development, but faces risks from life sciences CRM market saturation.
VEEV's strong Q1 and AI advancements indicate growth potential, but market saturation in life sciences CRM may hinder future performance, impacting investor sentiment and stock value.
Zacks.com users are showing increased interest in Veeva (VEEV), prompting a closer look at the stock's future prospects.
Increased attention on Veeva (VEEV) suggests potential stock volatility or investment interest, prompting investors to evaluate its performance and prospects.
Veeva Systems (VEEV) closed at $188.17, down 2.15% from the previous day's close.
Veeva Systems' decline of 2.15% indicates potential investor concerns, impacting market sentiment and could signal volatility or profit-taking opportunities.
Fundsmith Equity Fund decreased by 2.9% in the first half of the year, underperforming the MSCI World Index by 14.1 percentage points. GE Vernova and Nextpower are notable companies in energy technology.
Fundsmith's underperformance against the MSCI World Index signals potential issues in its investment strategy, impacting investor confidence. The mention of GE Vernova and Nextpower highlights growth sectors.
Wall Street analysts' ratings influence investor decisions on stocks, with changes in their recommendations impacting stock prices significantly.
Analyst ratings directly impact stock prices, influencing investor decisions and market trends, which can lead to increased volatility and opportunities for profit or loss.
Based on our analysis of 17 Wall Street analysts, Veeva Systems Inc. (VEEV) has a median price target of $235.00. The highest price target is $350.00 and the lowest is $165.00.
According to current analyst ratings, VEEV has 21 Buy ratings, 7 Hold ratings, and 1 Sell ratings. The stock is currently trading at $197.37. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict VEEV stock could reach $235.00 in the next 12 months. This represents a 19.1% increase from the current price of $197.37. Please note that this is a projection by Wall Street analysts and not a guarantee.
The company generates revenue by offering industry-specific cloud-based applications that assist life sciences organizations in managing key operational functions such as customer relationships, clinical trials, and compliance. By providing a platform that enhances data integrity and collaboration, Veeva Systems targets a diverse customer base that includes both emerging biotech firms and established pharmaceutical companies.
The highest price target for VEEV is $350.00 from at , which represents a 77.3% increase from the current price of $197.37.
The lowest price target for VEEV is $165.00 from Gabriela Borges at Goldman Sachs, which represents a -16.4% decrease from the current price of $197.37.
The overall analyst consensus for VEEV is bullish. Out of 17 Wall Street analysts, 21 rate it as Buy, 7 as Hold, and 1 as Sell, with a median price target of $235.00.
Stock price projections, including those for Veeva Systems Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.